Connect with us

Cannabis News

Swiss company launches nationwide price comparison tool for cannabis

Published

3 months ago

on











Evidena Care AG is one of the leading Swiss telemedicine platforms and specialized medical practices for medical cannabis. The company currently supports more than 2,000 patients across the country. Under the direction of Dr. Nicolai Berardi and two other specialist doctors, Evidena Care has focused on evidence-based, responsible and patient-centered treatment for the past two years.

Now, Evidena Care is launching a nationwide online comparison portal for medical cannabis products. The platform is designed for patients who already have a valid medical prescription and want a clear and reliable view of the market. For the first time in Switzerland, patients can directly compare products and prices from the country’s largest pharmacies in one place.

Medical cannabis plays an essential role in the treatment plans of many patients. At the same time, prices can vary significantly between pharmacies, even when the products contain the same levels of active ingredients. As these costs are often not covered by health insurance, or only partially covered, many patients have a heavy financial burden. The new portal addresses this issue by bringing transparency to a market that until now has been difficult to navigate.

The platform provides an overview of available products and dosages, clearly lists the active ingredient content, such as THC and CBD levels, and displays the current prices of leading Swiss pharmacies. Patients can directly compare options and make informed decisions that help optimize their therapy costs, without compromising medical guidance.

“Patients should not be victims of non-transparent pricing structures,” says Dr. Nicolai Berardi, CEO of Evidena Care AG. “We are creating transparency with our comparison portal, strengthening the self-responsibility of those affected and promoting fair competition in the interests of patients.”

The portal is only for people with a valid prescription. It serves as a true information tool and supports cost optimization in an existing therapy supervised by a physician.

For more information:
Evidena Care AG
Email: (email protected)
https://evidena.care/










Related Topics:
Continue Reading

Cannabis News

TSA clarifies that cannabis policy has not changed

Published

12 hours ago

on

May 24, 2026

By











Over the past week, many news organizations have been running exaggerated headlines about a supposed change by the federal government to allow marijuana to be brought into airports and airplanes. But it’s not true, the Transportation Security Administration (TSA) tells Marijuana Moment.

“TSA’s policy on medical marijuana has not changed,” a TSA spokeswoman said in an email Wednesday.

“According to the TSA website: If any illegal substance or evidence of criminal activity is found during the security screening, TSA will refer the matter to law enforcement,” they said. While it’s true that the agency’s list of medical marijuana “What can I bring?” section of its website was updated on April 27, there were no major changes in policy.

Currently, the website says “Yes,” passengers can carry medical marijuana in carry-on and checked bags with special instructions. But the TSA cannabis policy has said “Yes” to medical marijuana, with the same caveats, since 2019.

Read more at Marijuana Moment










Continue Reading

Cannabis News

Alabama Officials Move To Delay Automatic Rescheduling Of Marijuana Under State Law Following Trump’s Federal Move

Published

12 hours ago

on

May 24, 2026

By

“We’re not saying Alabama won’t do this. We’re definitely going to do this, but if you get it without objection, it’s scheduled right away.”

By Anna Barrett, Alabama Reflector

The governing body of the Alabama Department of Public Health voted Thursday against the federal rescheduling of marijuana, saying state health officials needed more time to determine how to implement it.

Dr. Scott Harris, Alabama’s top health official, told members of the state’s Public Health Commission that the state has “full intent” to implement the change.

“We’re not saying Alabama won’t do this,” Harris told the committee. “We’ll certainly do this, but if you get it without objection, it’s scheduled immediately. If you do nothing, it’s scheduled within 30 days. I’m going to ask you to take the third option, which is to oppose it. Then we just have a little time to figure this out with all our other stakeholders.”

The committee’s vote was unanimous. Brian Hale, ADPH’s legal director, said the objection would be open to public comment during the meeting. This period would last 30 to 60 days.

“The objection is simply to allow more time for input on the implications of this rescheduling,” Hale said. “There will be a public hearing, we’ll see the comments that way, and then we’ll talk to other stakeholders, licensing boards and others who might be affected to see what their input might be.”

In April, the US Department of Justice (DOJ) moved marijuana from Schedule I — the Drug Enforcement Administration’s (DEA) list of drugs with the least amount of abuse and legal use — to Schedule III, which, according to the DEA, drugs have a moderate to low potential for physical and psychological dependence. The order followed an executive order President Donald Trump signed in December to keep the DOJ on track to reschedule.

Former President Joe Biden ordered the DOJ to reschedule the drug in 2024, but hearings on the move were canceled in early 2025.

The federal mandate applies to medical marijuana products in states that allow the use of the drug. The move means those businesses can deduct business expenses from federal taxes and investigators have access to legal products in the state. As a Schedule I drug, only cannabis grown in a federal facility could be researched, greatly limiting the supply available to researchers.

Alabama has a medical cannabis program approved by the Legislature in 2021. A Montgomery The dispensary said last week it hopes to make medical marijuana available to patients soon. A message seeking comment from Vince Schillec, the dispensary’s owner, was left Thursday afternoon.

Harris said the reconsideration would not violate state law, but after speaking with the Alabama Medical Cannabis Commission (AMCC), he was unsure how the reconsideration would affect the program.

“We’ve worked very hard to try to figure out what the ramifications of this are. There are a number of things that don’t completely conflict with state laws or other regulations, but they require some thought as to how to implement them,” Harris said.

Justin Aday, AMCC’s general counsel, said in a telephone interview that the commission does not foresee any immediate impact from the federal reorganization or a delay in the reorganization at the state level.

“We certainly understand the commission and the desire to gather additional information about the implications of the federal reorganization and what the implications would be, depending on how medical cannabis is scheduled at the state level,” Aday said. “We will certainly participate in that process as necessary, and we will provide all the information we can.”

This story was first published by the Alabama Reflector.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Continue Reading

Cannabis News

New California emergency marijuana rules aim to help state businesses

Published

2 days ago

on

May 23, 2026

By











California officials are making additional reforms to help the state’s marijuana businesses take advantage of federal tax and other benefits under the Trump administration’s redistricting move.

Specifically, the Department of Cannabis Control (DCC) proposed emergency regulations on Monday to allow companies with current licenses that use both medical and adult marijuana to secure a secondary license through a simplified process to separate the segments of their operations, as federal planning changes currently only cover medical cannabis.

Under the DCC’s proposal, marijuana companies could “create a second entity and hold two separate licenses (one for adult use and one for medicinal use) on the same premises” under the expedited regulations.

“DCC is working to make this pathway available due to the timing and uncertainty of the federal process,” the department said. “Additional operational components (such as tracking and tracing requirements, local permitting, tax collection, and other implementation issues) are still being evaluated and will be addressed through future guidance or rulemaking as needed.”

Read more at Marijuana Moment










Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media